Related Experiment Video
Updated: Jun 10, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Intermediate conductance calcium-activated potassium channel (KCa3.1) in cancer: Emerging roles and therapeutic
Nhung Thi Hong Van1, Joo Hyun Nam1
1Department of Physiology, Dongguk University College of Medicine, Gyeongju 38066, Republic of Korea; Channelopathy Research Center (CRC), Dongguk University College of Medicine, Goyang 10326, Republic of Korea.
Abstract:
The KCa3.1 channel (also known as the KCNN4, IK1, or SK4 channel) is an intermediate-conductance calcium-activated potassium channel that regulates the membrane potential and maintains calcium homeostasis. Recently, KCa3.1 channels have attracted increasing attention because of their diverse roles in various types of cancers. In cancer cells, KCa3.1 channels regulate key processes, including cell proliferation, cell cycle, migration, invasion, tumor microenvironments, and therapy resistance. In addition, abnormal KCa3.1 expression in cancers is utilized to distinguish between tumor and normal tissues, classify cancer stages, and predict patient survival outcomes. This review comprehensively examines the current understanding of the contribution of KCa3.1 channels to tumor formation, metastasis, and its mechanisms. We evaluated the potential of KCa3.1 as a biomarker for cancer diagnosis and prognosis. Finally, we discuss the advances and challenges of applying KCa3.1 modulators in cancer treatment and propose approaches to overcome these obstacles. In summary, this review highlights the importance of this ion channel as a potent therapeutic target and prognostic biomarker of cancer.
Insights
The KCa3.1 channel plays a key role in cancer progression and therapy resistance. Understanding its function offers potential for new cancer diagnostics and treatments.
Area of Science:
- Biophysics
- Molecular Biology
- Oncology
Background:
- The KCa3.1 channel (KCNN4/IK1/SK4) is a calcium-activated potassium channel crucial for cellular functions.
- KCa3.1 channels are increasingly recognized for their significant involvement in various cancer types.
Purpose of the Study:
- To comprehensively review the role of KCa3.1 channels in cancer development, metastasis, and therapeutic resistance.
- To evaluate KCa3.1 as a potential biomarker for cancer diagnosis and prognosis.
- To discuss the therapeutic potential and challenges of KCa3.1 modulators in cancer treatment.
Main Methods:
- Literature review of current research on KCa3.1 channels in cancer.
- Analysis of KCa3.1's contribution to cancer cell proliferation, migration, invasion, and tumor microenvironment.
- Evaluation of KCa3.1 expression patterns in cancer for diagnostic and prognostic applications.
Main Results:
- KCa3.1 channels regulate critical cancer cell processes like proliferation, migration, and invasion.
- Abnormal KCa3.1 expression is linked to cancer staging and patient survival outcomes.
- KCa3.1 modulators show promise but face challenges in clinical application for cancer therapy.
Conclusions:
- KCa3.1 channels are integral to tumor formation and progression, making them a significant therapeutic target.
- KCa3.1 serves as a valuable prognostic biomarker for predicting patient outcomes in cancer.
- Further research into KCa3.1 modulators is essential to overcome therapeutic challenges and improve cancer treatment strategies.
Related Concept Videos
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
The Role of Ion Channels in Neuronal Computation
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential....
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Targeted Cancer Therapies
There are several types of targeted therapies against...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...

